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Proinsulin biosynthesisge amounts of one or more peptides. The post-translational control of selective
production of a single protein is often unknown. We used 3 unrelated approaches to diminish PKCε in rat
islets to evaluate its role in preferential glucose-mediated insulin production. Transfection with siRNA (siR-
PKCε) or expression of inactive PKCε (PKCε-KD) resulted in a signiﬁcant reduction in insulin response to
glucose (16.7 mmol/l). Glucose stimulation resulted in concentration of PKCε in the perinuclear region, an
area known to be rich in ER–Golgi systems, associated with insulin-containing structures. ß’COP1 (RACK2) is
the anchoring protein for PKCε. Glucose-stimulated proinsulin production was diminished by 50% in islets
expressing PKCε-KD, and 60% in islets expressing RACK2 binding protein (εV1-2); total protein biosynthesis
was not affected. In islets expressing εV1-2, a chase period following glucose stimulus resulted in a reduced
proinsulin conversion to mature insulin. We propose that PKCε plays a speciﬁc role in mediating the glucose-
signal into insulin production: binding to ß’COP1 localizes the activated enzyme to the RER where it
modulates the shuttling of proinsulin to the TGN. Subsequently the enzyme may be involved in anterograde
trafﬁcking of the prohormone or in its processing within the TGN.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionHighly specialized cells, such as hormone producing cells, produce
one or two peptides at much higher rates than all other cellular
proteins. Little is known on the mechanism of selectivity of this
process. In pancreatic β-cells glucose metabolism affects most major
signal pathways, including those of insulin production, storage and
exocytosis [1,2]. Multiple families of protein kinases are known to
function downstream to glucose metabolism; however the precise
role of many is poorly deﬁned [3]. Several subtypes of these kinases
are also activated by receptor-generated signals and thusmay function
as the site of convergence of the metabolic signals with those
generated by hormones and neurotransmitters.When activated, many
protein kinases, including the protein kinase C family, translocate to
the site of their effectors and bind an anchoring protein which keeps
them in close proximity of their downstream target [4]. We identiﬁed
six isoforms of PKC in rat β-cells, four of which, PKCα, PKCε, PKCζ and
PKCθ, exhibited glucose-induced activation and translocation [5].tein kinase C; RACK2, receptor
, area under the curve; siRNA,
idylinositol 3,4,5-triphosphate;
ressure liquid chromatography
bolism Service, The Hebrew
, 91120 Jerusalem, Israel. Tel.:
l rights reserved.Abnormalities in level or translocation characteristics in response to
glucosewere observed for PKCα, PKCε, PKCζ, PKCδ, and PKCθ in β-cells
of the GK rat, a rodent with spontaneous type 2-like diabetes [5].
Using anchoring-competing short peptides, we have also shown that
inhibition of translocation of PKCα and PKCε diminishes insulin
release from isolated rat islets, the former in a calcium-dependent
mode and the latter in a calcium-independent manner [6].
Histochemical analyses indicated a strong association of PKCα and
PKCε with insulin granules and with their movements during the
biphasic dynamics of glucose-induced insulin secretion [5]. In other
cells, PKCεhas been reported toplayanessential role indiverse signaling
systems related to cell proliferation [7–10], gene expression [7,10], and
vesicle trafﬁcking and exocytosis [10]. β′COP-1, or RACK2, which is a
member of the COP complex involved in the shuttling of newly formed
proteins, has been identiﬁed as PKCε's anchoring protein [10,11] and is
responsible for maintaining the activated form of the enzyme in close
proximity of its effector protein(s) [4,12]. Because we observed that
glucose stimulation led to concentration of PKCε in the perinuclear
region in β-cells [5], in the present studywe explored the role of PKCε in
insulin production and secretion in rat islets of Langerhans.
2. Materials and methods
2.1. Animals
Male Wistar rats (Harlan Animal Farms, Jerusalem) weighing 180–200 g were used
for islet perifusion and for biosynthesis studies, while 250–300 g males were used for
pancreas perfusion. Animal usage was with full adherence to Institutional Ethical
Committee guidelines. For perfusion studies, rats were anesthetized by IP injection of
Fig. 2. Diminished PKCε levels or activity in isolated rat islets. A: Quantitative Western
blot of PKCε levels, corrected for levels of GAPGH, in rat islets transfected with siR-PKCε.
Control isletswere transfectedwith an inactive sequence of 21mer siRNA. B: Diminished
novel PKC activity in isolated islets infected by adenovirus expressing mutant PKCε,
PKCε-KD. Control islets were infected with the adenovirus devoid of added sequence. A
and B are means±SD of 3 determinations.
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perfusion as previously described [13,14]. The pancreas was ﬁxedwith 4% formaldehyde
in PBS by a brief perfusion, and kept at 4 °C in PBS until staining and imaging [5,15].
2.2. Islets
Rat islets were isolated by collagenase digestion (Collagenase P; Roche, Boehringer-
Mannheim, Mannheim, Germany) as previously described [14], hand picked andwashed
3 times in Hanks solution. Islets were cultured in bacteriological dish in RPMI 1640
medium, containing 10% fetal bovine serum,100 U/ml penicillin, 0.1 mg/ml streptomycin
and 2.0 mmol/l L-Glutamine (all from Biological Industries, Beit Haemek, Israel).
2.3. Immunohistochemical staining and imaging
Pancreata were sectioned, stained and imaged using a Zeiss LSM 410 confocal laser
scanning system attached to the Zeiss Axiovert 135 M inverted microscope as
previously described [5]. Antibodies for PKCε histochemistry and for Western blot
were obtained from Sigma-Aldrich Biochemicals (Rehovot, Israel).
2.4. siRNA
Double-strand 21 mer siRNA (siR-PKCε) was designed as described in detail by
Elbashir et al. [16] (Fig. 1A) and ordered from Dharmacon (Dharmacon Inc. Chicago, IL).
The DS Scrambled Negative was from IDT (Integrated DNA Technologies, Coralville, IA).
DS siRNA-containing micelles were prepared by mixing 5 µl Lipofectamine 2000
(Invitrogen Corporation, Carlsbad, California, USA) and 100 µl OptiMEM (Invitrogen)
and transfected as described by the manufacturer in an antibiotic-free medium. The
ﬁnal concentration of siRNA was 100 nmol/l. Transfection medium was replaced after
6 h with the regular growth medium (RPMI), and the islets were maintained in culture
for three additional days. Efﬁciency of penetration was monitored in INS-1E cells using
5’-Cye3 labeled inactive construct (Dharmacon) followed by FACS analysis 16 h after
transfection, and was routinely N94%. In isolated islets, the efﬁciency was monitored by
confocal imaging of the same construct using 5 µm apart z-plane sections
(Supplementary Fig. 1). Efﬁciency of PKCε shutoff was estimated by Western blot and
densitometric analysis using Tina 2.0 Image Analysis software (an open source library
and toolkit), and ranged between 60% and 80% (Fig. 2A).
2.5. Expression of PKCε
The adenoviruses expressing kinase-dead PKCε (PKCε-KD) or authentic PKCε ([17]
(Fig. 1B) were kindly provided by Drs. T. Kuroki, Showa University, Tokyo and T.
Tennenbaum, Bar-Ilan University, Israel. The virus was propagated in HEK 293 cells
grown in DMEM medium (Biological Industries). Freshly isolated islets were infected
with 200 IFU/islet in RPMI medium (Biological Industries) and incubated overnight at
37 °C. Levels of PKCε expression were determined by Western blot using anti-PKCε
antibody (Sigma, see Section 2.3 above) and islets treated with control adenovirus were
used as reference for basal levels of PKCε. Reduction in novel PKC activity in isletsFig. 1. A–C: The three unrelated procedures used to diminish PKCε activity in rat
pancreatic β-cells. A: The RNAi, siR-PKCε; B: the expression of inactive PKCε, PKCε-KD;
C: map of the adenovirus expressing a short peptide that competes with PKCε for
RACK2, εV1-2, a translocation-inhibitory peptide generated from the V1 region of PKCε
[11]. The scrambled sequence is also illustrated.infected with PKCε-KD was 70% (Fig. 2B), determined by SignaTECT PKC Activity Assay
(Promega, Madison WI). For novel PKC activity assay, endogenous phospholipids were
removed by DE52 column extractions and calcium was excluded using EGTA, thus
eliminating the contribution of the Classical family of isoenzymes. The activity of the
atypical family of isoenzymes was subtracted using duplicate extracts activated by
phospholipids alone. Data shown in Fig. 2B are the net DAG-activated fractions, in theFig. 3. The effect of diminished PKCε activity on the dynamics of insulin response to
glucose in perifused rat islets. A: Control islets; islets expressing active PKCε, PKCε-WT;
or inactive PKCε, PKCε-KD. B: Control islets, islets transfected with siR-PKCε, or with
scrambled PKCε, scrb-PKCε. Each line represents means of 4–9 studies.
Table 1
Biphasic insulin response to glucose during diminished PKCε activity
First phase Second phase
(ng/50 isl/6 min) (ng/50 isl/h)




Area under the insulin release curves in response to glucose in isolated perifused rat
islets. Cont., islets transfected with inactive, scrambled siRNA; PKCε-DN, islets
expressing inactive PKCε at 5 fold concentrations of control islets as determined by
densitometric evaluation of Western blot analysis; PKCε-WT, islets expressing active
PKCε at 5 fold concentrations; siR-PKCε, islets transfected with siRNA to diminish PKCε
levels. Data are means±SEM of 4–9 observations; #, pb0.001 vs. control; ¶, pb00.05 vs.
PKCε-WT; ⁎, pb0.001 vs. control.
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phosphatidylserine and without DAG.
2.6. Translocation-inhibitory peptides
Plasmids coding for PKCε translocation-inhibitory peptide (εV1-2) and for
scrambled control (εV1-2s) were kindly provided by Dr. D. Mochly-Rosen, Stanford
University, CA, and inserted into adenoviral vectors. Single-strand nucleotide sequences
for peptides generated from the V1 region of PKCε and for the scrambled controls were
inserted into pEGFP-C1 adenoviral vector as described in detail by He et al. [18] (Fig 1C).
2.7. Insulin synthesis
Batches of 25 islets were used in a ﬁnal volume of 500 μl to study total protein and
proinsulin biosynthesis. Islets were preincubated in 3.3 mmol/l glucose for 60min, then
further incubated for 1 h in Krebs Ringer Bicarbonate (KRB) solution containing
16.7 mmol/l glucose, then for an additional 15 min in the same buffer supplemented
with 25 μCi 3H-leucine (leucine, L-2, 3, 4, 5-3H, American Radiolabeled Chemicals, Inc.,
St. Louis, MO). For proinsulin processing studies, following the labeling period, the
medium was changed to KRB with 3.3 mmol/l glucose supplemented with 1.0 mmol/l
non-labeled leucine. The studies were terminated by the addition of 1.0 ml glucose-free
KRB solution, centrifugation, and addition of 500 μl GB/NP40 buffer (0.2 mol/l glycine
buffer containing 0.1% RIA grade BSA and 0.5% NP-40, pH 8.8) to the precipitate. For
determination of total insulin I+ II plus proinsulin, 50 ml samples were pre-treated with
4.5 mg Protein A-Sepharose beads (Sigma-Aldrich) in 100 μl of GB/NP40 buffer by
shaking at room temperature for 1 h. After centrifugation (1000 RPM, 1 min), the
supernatant was transferred to fresh beads of Protein A-Sepharose, suspended in GB/
NP40 buffer; anti-insulin antibody (1/25 dilution, Sigma-Aldrich) was added, and the
mix was incubated using gentle shaking for 1 h at room temperature. The antiserumFig. 4. Translocation of PKCε to the perinuclear region in pancreatic β-cells, 15 min after the
glucose stimulation (16.7 mmol/l) or perfused with basal buffer (3.3 mmol/l glucose), then ﬁx
PKCε and insulin. Pancreatic sections were imaged by confocal microscopy. Signal intensity
increasing signal intensity, respectively. A total of 48 recorded ﬁelds, obtained from 4 basal an
and compared with an earlier time point to determine statistical changes in the enzyme local
perinuclear concentration of PKCε as compared with 5 min post-stimulation (pb0.0001). (S(Sigma I-8510) was evaluated for cross-reactivity with proinsulin by comparing the
labeled insulin+proinsulin recovered by immunoprecipitation and by RP-HPLC in
identical samples. Incubation was terminated by centrifugation at 1000 RPM for 1 min,
two washes of the precipitate with GB/NP40 buffer, and the addition of 100 μl water.
Scintillation ﬂuid (4.5 ml, QuickSafe A, Zinsser Analytic, Frankfurt, Germany) was added
and the sample was counted using TriCarb 1500 beta counter (Packard Instrument,
Downers Grove, IL). Production of insulin and insulin intermediates was determined by
the RP-HPLC separation protocol as described by Gadot et al. [14] modiﬁed after Halban
et al. [19] and Zambre et al. [20]. For the determination of total newly synthesized
protein, 0.5 ml of 0.1% BSA was added to 20 ml of sample, followed by 0.5 ml 20%
trichloroacetic acid (TCA). Following 20 min of standing on ice, the sample was washed
twice with 10% TCA by ﬁltration through a Whatman GF/A ﬁlter, dried, and counted in
8 ml QuickSafe A as above.
2.8. Insulin assay
In dynamic islet perifusion studies, basal samples (2.5 mmol/l glucose) were
collected every 5 min, then during glucose stimulation (16.7 mmol/l) every minute for
the ﬁrst 10 min, followed by 5 min collections for the rest of the study. Net area under
the curve (AUC) insulin released during the initial 6 min of stimulation was calculated
for 1st phase insulin response and for 2nd phase insulin release, the subsequent 60 min
was used. Insulin was determined using Rat Insulin RIA kit (Linco Research, St. Charles,
Missouri, USA). Mean CV between assays was 8.9%, within assay 2.2%.
2.9. Statistical analyses
Kruskal–Wallis nonparametric ANOVA followed by Tukey–Kramer test was used to
compare between the experimental conditions with 95% conﬁdence level. Data was
analyzed using InStat statistical software (GraphPad Software, San Diego, CA).
3. Results
3.1. Inhibition of PKCε reduces insulin release
Using cultured rat islets or mouse β-cells, we [6] as well as Mendez
et al. [21] have shown that PKCε plays a role in the insulin response to
glucose. To further elucidate the role of PKCε in the dynamics of insulin
response to glucose,we employed twounrelated approaches in isolated
rat islets to diminish endogenous PKCε activity: expression of inactive
PKCε (PKCε-KD) anddepletion of PKCε by siRNA (siR-PKCε). Fig. 3 shows
that the two approaches resulted in similar results. Expression of PKCε-
KD at 5 fold basal levels, resulting in 70% inhibition of novel PKC activity
(Fig. 2B), led to inhibition of the insulin response to glucose (Fig. 3A).
Likewise, diminished PKCε levels using siR-PKCε (routinely between
60% and 80% reduction, Fig. 2A), led to a similar inhibition of the insulinonset of glucose stimulus. The isolated perfused rat pancreas was subjected to a 15-min
ed with 4% formaldehyde in PBS by perfusion, and the sections were double stained for
is presented as color scale: blue-background; green, red and bright orange, represent
d 4 stimulated pancreata, were scanned and quantitatively analyzed. Analysis was done
ization. At 15 min of stimulationwith glucose, 67% of the scanned β-cell ﬁelds displayed
cale bar=5 µm).
Fig. 5. Inhibition of PKCε results in diminished glucose-stimulated proinsulin
production. Isolated rat islets expressing PKCε-KD (A), or εV1-2 (C), were stimulated
with 16.7 mmol/l glucose for 75 min, and pulse-labeled with 3H-leucine during the ﬁnal
15 min. Islet extracts were subjected to immunoprecipitation with insulin/proinsulin
antibody or analyzed by RP-HPLC and proinsulin production determined as fraction of
total newly synthesized proteins (A), or of total insulin-related products (C). Shown are
means±SE of 5–8 experiments; ⁎=pb0.01. (B) No difference in total newly synthesized
(TCA precipitate) protein was observed in islets expressing PKCε-KD.
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unaffected by infection with adenovirus expressing PKCε-KD or by
transfection with siR-PKCε: in control, non-treated islets, basal insulin
secretion was 0.26±0.06 ng/50 islets/min; in islets transfected with
scrambled siRNA, 0.29±0.07 ng/50 islets/min; in islets transfectedwith
siR-PKCε, 0.35±0.09 ng/50 islets/min; in islets infectedwith adenovirus
expressing PKCε-KD, 0.30±0.09 ng/50 islets/min; in islets infectedwith
adenovirus expressing PKCε-WT, 0.20±0.06 ng/50 islets/min (none
signiﬁcantly different). No change in insulin response was observed in
islets infected with adenovirus over-expressing authentic PKCε (PKCε-
WT) as comparedwith untreated islets (Fig. 3A), indicating that in non-
treated islets, the enzyme was not rate-limiting in the exocytotic
pathway. Transfection with an inactive (scrambled) construct of siRNA
had no signiﬁcant effect on rates of insulin response to glucose.
Integrated evaluation (AUC) of the phasic response to glucose (Table 1)
revealed a modest, but non-signiﬁcant, decline of 1st phase insulin
response (6 min) to glucose by treatment with either PKCε-KD or siR-
PKCε. A signiﬁcant decline in insulin response was seen in AUC during
the 2nd phase (subsequent 1 h): the expression of PKCε-KD resulted in
nearly 80% decline in insulin release and transfection with siR-PKCε
resulting in 83% inhibition (Table 1).
3.2. Localization of activated PKCε
ß’COP1, a component of the COP1 trafﬁcking complex was reported
to be a speciﬁc anchoring protein for PKCε [11] This led us to consider
the possibility that the inhibitory effect of PKCε on glucose-dependent
insulin release could be related to a reduction in insulinproduction. The
pool of newly synthesized hormone is known to be preferentially
released upon glucose stimulation [22–25]. Fig. 4 shows that 15 min of
stimulation of the isolated perfused rat pancreas with 16.7 mmol/l
glucose resulted in concentration of the activated enzyme in granulated
structures in the perinuclear region, known to be rich in ER and Golgi
membranes. Within this short time frame, the majority of these
perinuclear structures exhibited a signal super-imposable with insulin
(or proinsulin), indicative of association with the insulin producing or
storing structures. Forty-eight ﬁelds obtained from random sections of
4 control and 4 glucose-stimulated pancreata were imaged; 67% ﬁelds
of pancreatic islets displayed glucose-induced β-cell perinuclear
concentration of PKCε in association with insulin staining.
3.3. PKCε controls biosynthetic pathways
Given that PKCε localized to insulin-staining structures in the
perinuclear regions, we next determined its role in the pathways of
insulin production. Rat islets were infected with adenovirus expres-
sing PKCε-KD, or εV1-2, stimulated with glucose for 75min and pulse-
labeled with 3H-leucine for the ﬁnal 15 min as described. Immediately
at the end of the 75 min glucose stimulus, total islet proteins were
extracted and subjected to immunoprecipitation with anti-insulin
antibodies, or loaded on RP-HPLC for analysis of newly produced
insulin-like products. At the end of 15 min labeling (0 time), the
radioactivity recovered in the HPLC proinsulin peaks in non-infected
control islets was 76,103±22,326 DPM/25 islets, N=8; in infected
control islets expressing EGFP alone, 79,399±12,608 DPM/25 islets
were measured, N=6; in infected control islets expressing εV1-2s,
108,840±16,234 DPM/25 islets were measured, N=5, (means±SEM,
none signiﬁcantly different). The insulin antibody was selected for its
full cross-reactivity with proinsulin (see Materials and methods),
therefore the products obtained by precipitation at the end of 15 min
labeling would mostly be proinsulin. Islets expressing PKCε-KD
produced 50% less proinsulin following the 15-min labeling, as
compared to control islets as shown in Fig. 5A (pb0.01). The
expression of inactive PKCε had no effect on total glucose-stimulated
protein synthesis (Fig 5B) (p=NS). Similarly, at the end of the glucose
stimulation, newly formed insulin-related products in islets infectedwith adenovirus expressing εV1-2 were more than 60% less than that
observed in islets infected with adenovirus expressing the scrambled
form of the peptide, εV1-2s (pb0.01) (Fig. 5C).
3.4. PKCε regulates proinsulin conversion to insulin
We next examined whether PKCε was also involved in the
conversion of proinsulin to mature insulin I and II. Isolated rat islets
were infected with adenovirus expressing the RACK2-competing
peptide (εV1-2), and stimulated with 16.7 mmol/l glucose for
75 min; the ﬁnal 15 min was pulsed with 3H-leucine, then a 90-min
chase period with 3.3 mmol/l glucose and 1.0 mmol/l leucine was
applied (for details see Materials and methods). Islet proteins were
analyzed by RP-HPLC as outlined [14,26]. The overall labeling in the
control proinsulin peaks was 107,567±10,170 DPM/25 islets in the
Fig. 6. PKCε affects early steps in the glucose-dependent processing of proinsulin. Isolated
rat islets expressing εV1-2 or its scrambled control εV1-2s were stimulated with
16.7mmol/l glucose for 75min andpulse-labeledwith 3H-leucine during theﬁnal 15min.
Islet extracts were analyzed by RP-HPLC after 90 min chase with basal (3.3 mmol/l)
glucose in the presence of excess leucine. Open bars represent control; grey bars, εV1-2;
black bars, εV1-2s. Means±SE of 7–11 experiments; ⁎=pb0.05.
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adenovirus expressing EGFP alone and 127,125±19,187 DPM/25 islets
in islets expressing the εV1-2s peptide (means±SEM, none signiﬁ-
cantly different). Fig. 6 presents the mean data of the individual peaks
obtained in 7–11 studies, illustrating the relative amounts of
proinsulin, insulin I+ II, C-peptide and the insulin-related conversion
intermediates detected at the end of the 90-min chase period.
Diminished glucose-induced translocation of PKCε by εV1-2 led to a
reduction in C-peptide and a small decrease in insulin fractions (insulin
I+ insulin II) compared to control islets or as compared with islets
infected with adenovirus expressing the scrambled peptide, εV1-2s.
These changes were signiﬁcant for C-peptide (pb0.05) but not for
insulin. Most signiﬁcantly, the expression of εV1-2 resulted in the
doubling of the fraction of proinsulin as compared to control (16%±3%
vs. 8%±1%) or to islets expressing εV1-2s (16%±3% vs. 8%±2%) (both
pb0.05). Finally, insulin-related conversion intermediates were also
somewhat increased as compared to control islets or to islets
expressing the scrambled peptide εV1-2s (22%±4% vs.15%±2% control;
22%±4% vs. 13%±2% for εV1-2 vs. εV1-2s) (both NS). This analysis
suggests that PKCεmay affect two sites: the transport of proinsulin to
the TGN, as well as its movement within the TGN, thus affecting its
anterograde trafﬁcking and the processing tomature insulin. The study
also demonstrates that adenoviral infection and the expression of
scrambled peptide had no effect on the synthesis of any of the insulin-
related materials.
4. Discussion
Glucose metabolism controls the most essential functions in
pancreatic β-cells through multiple complex pathways (reviewed in
[1,2]). Several protein kinases play key functions in these cells,manyalso
serve as cross points for signals originating from glucose metabolism
and from activated receptors. Insulin synthesis as well as the synthesis
of most other β-cell proteins is regulated by glucose metabolism; many
components of this pathway are poorly deﬁned. Glucose-enhanced
overall protein synthesis has been linked with dephosphorylation of
eIF2a and the formation of eIF2–GTP–Met-tRNA initiation complex [27],
but the post-translational mechanism of glucose-selective production
of insulin, amajor component of theβ-cell, is unknown.Wehave shown
that glucose activated at least 6 isoforms of the PKC family, each with a
unique kinetics and speciﬁc localization [5,6]. At the onset of the 1st
phase (2min), glucose-triggered co-localization of PKCε and insulinwas
observed near the β-cell membrane and subsequently, during the 2nd
phase (N15 min) in the perinuclear region [5]. The latter persisted for
more than 15 min following the cessation of the glucose stimulus.
Stimulus-induced localization of PKCε to the ER–Golgi complex was
reported in other cells (reviewed in [10]), and importantly, β′COP1, avesicular trafﬁcking protein, was the ﬁrst speciﬁc anchoring protein
(RACK2) identiﬁed for PKCε [11,28,29].
We next considered that the effect of inhibition of PKCε targeted
the newly synthesized insulin, a pool of hormone preferentially
released upon glucose stimulation [22–25]. Thus, the identiﬁcation
of ß’COP1 as the speciﬁc anchoring protein for PKCε prompted us
to investigate the role of PKCε in vesicular trafﬁcking in pancreatic
β-cells. Indeed, employing three unrelated mechanisms to diminish
β-cell activity of PKCε we were able to show that PKCε is involved in
glucose-driven synthesis of insulin. The effect was quite early in the
biosynthetic route: when evaluated at time 0, immediately after a
short pulse with 3H-leucine, production of proinsulin was strongly
diminished under both conditions of diminished PKCε activity.
Furthermore, PKCε was apparently required for further steps of the
transport and processing of proinsulin, since 90 min after the glucose
pulse, fractional C-peptide was signiﬁcantly reduced, whereas the
related insulin I and II and intermediate insulin split products were
reduced but to a lesser extent (not signiﬁcantly). Correspondingly, the
fraction of proinsulin doubled in islets with diminished PKCε activity.
Thus, PKCε could be the important linking kinase between glucose
metabolism and insulin production, exerting its control at an early
post-translational level. Its speciﬁcity was demonstrated from the lack
of PKCε-dependent effects on newly synthesized total proteins.
Glucose-induced re-localization of PKCε to an area rich in ER and
the trans Golgi network (TGN) was previously observed, and clearly
illustrated here using the rat perfused pancreas preparation. Double
staining also conﬁrmed association with insulin-containing struc-
tures. The dramatic depletion in proinsulin production implies that
PKCε plays an important part in recognition or anterograde trafﬁcking
of the newly produced proinsulin from the ER to the TGN, prior to
further processing and packaging. In fact, the speciﬁc binding to β′COP
would position PKCε action at this site. The reduction of proinsulin at
an early time, before processing by the convertase PC1/3 reaches
signiﬁcant level, may indicate that the reduced transfer of proinsulin
from the ER to the TGN leads to translational block and the elimination
of the newly synthesized protein.We have never observed localization
of PKCε within the nucleus, and therefore a transcriptional inhibitory
action seems unlikely.
The speciﬁc role played by PKCε in glucose-dependent insulin
production raises the question of which linking signal originates from
glucose metabolism. DAG, PIP3 and some fatty acids were reported as
physiological stimuli of PKCε in other systems [10]. Subcellular
localization of PKCεmay partially depend onwhich secondmessenger
binds to its C1 domain: in some systems translocation to the plasma
membrane and cytoskeleton was induced by DAG and tridecanoic
acids, whereas localization to the TGNwas induced by arachidonic and
linoleic acids [30]. In pancreatic β-cells, glucose metabolism is known
to promote, directly or indirectly, the production of all four messen-
gers. The association of PKCεwith β′COP occurs at the C2 domain, the
domain that also binds phospholipids [10]. This needs to be reafﬁrmed
in pancreatic β-cells. The target protein within the biosynthetic
machinery for activated PKCε is yet unclear. Several non-vesicular
proteins were reported to be targets for activated PKCε, none yet
linked to early or late shuttling of newly translated peptides.
Schmitz-Peiffer et al. recently reported improved glucose tolerance,
increased insulin production and reduced insulin disposal in transgenic
mice with total body PKCε knockout [31]. Albeit inconsistent with our
data utilizing islet-speciﬁc targeting methodology, it is however,
impossible to preclude that extended, overall PKCε knockout may
induce or activate alternative, undetermined signal pathways in the
islet. The report that increased insulin production was typically sig-
niﬁcant in mice fed high fat diet would support the assumption that
additional, PKCε-unrelated signals could be potentiated in the PKCε−/−
mice.
In summary, the data presented here suggests that PKCε plays an
important role in the transport of newly synthesized proinsulin from
1934 N. Warwar et al. / Biochimica et Biophysica Acta 1783 (2008) 1929–1934the ER to the TGN. By affecting anterograde shuttling of the newly
formed proinsulin, the enzyme may facilitate the processing of the
prohormone to insulin. With interference in this function, diminished
PKCε would overload the SER or ER with proinsulin, which would be
promptly directed to a degradative pathway, resulting in diminished
levels of proinsulin in that compartment. These effects of PKCε on the
biosynthetic route of newly formed insulin may account for its
indirect effect on glucose-triggered insulin secretion.
Acknowledgements
The authors wish to thank N. Kaiser, D. Gross and Y. Ariav for the
technical advice. We are grateful to D. Mochly-Rosen for the εV1-2
plasmid and to T. Tenenbaum and T. Kuroki for the adenoviruses
expressing PKCs. This work was supported in part by a grant from
the Hadassah Medical Organization and a grant from Les Labor-
atoires Servier, France. N.W. was a fellow of the Israel Ministry of
Science, Culture and Sport and of the Hebrew University Diabetes
Center.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.bbamcr.2008.04.007.
References
[1] F. Schuit, D. Flamez, A. De Vos, D. Pipeleers, Glucose-regulated gene expression
maintaining the glucose-responsive state of beta-cells, Diabetes 51 (Suppl 3) (2002)
S326–S332.
[2] J.T. Deeney, M. Prentki, B.E. Corkey, Metabolic control of beta-cell function, Semin.
Cell Dev. Biol. 11 (2000) 267–275.
[3] P.M. Jones, S.J. Persaud, Protein kinases, protein phosphorylation, and the
regulation of insulin secretion from pancreatic beta-cells, Endocr. Rev. 19 (1998)
429–461.
[4] D. Schechtman, D. Mochly-Rosen, Adaptor proteins in protein kinase C-mediated
signal transduction, Oncogene 20 (2001) 6339–6347.
[5] N. Warwar, S. Efendic, C.G. Ostenson, E.P. Haber, E. Cerasi, R. Nesher, Dynamics of
glucose-induced localization of PKC isoenzymes in pancreatic beta-cells: diabetes-
related changes in the GK rat, Diabetes 55 (2006) 590–599.
[6] M. Yedovitzky, D. Mochly-Rosen, J.A. Johnson, M.O. Gray, D. Ron, E. Abramovitch, E.
Cerasi, R. Nesher, Translocation inhibitors deﬁne speciﬁcity of protein kinase C
isoenzymes in pancreatic beta-cells, J. Biol. Chem. 272 (1997) 1417–1420.
[7] V.U. Rao, H. Shiraishi, P.J. McDermott, PKC-epsilon regulation of extracellular
signal-regulated kinase: a potential role in phenylephrine-induced cardiocyte
growth, Am. J. Physiol. 286 (2004) H2195–H2203.
[8] D.Wu, T.L. Foreman, C.W. Gregory,M.A.McJilton, G.G.Wescott, O.H. Ford, R.F. Alvey,
J.L. Mohler, D.M. Terrian, Protein kinase Cepsilon has the potential to advance the
recurrence of human prostate cancer, Cancer Res. 62 (2002) 2423–2429.
[9] T.R. Xu, M.G. Rumsby, Phorbol ester-induced translocation of PKC epsilon to the
nucleus in ﬁbroblasts: identiﬁcation of nuclear PKC epsilon-associating proteins,
FEBS Lett. 570 (2004) 20–24.
[10] Y. Akita, Protein kinase C-epsilon (PKC-epsilon): its unique structure and function,
J. Biochem. 132 (2002) 847–852.[11] M. Csukai, C.H. Chen, M.A. De Matteis, D. Mochly-Rosen, The coatomer protein
beta′-COP, a selective binding protein (RACK) for protein kinase Cepsilon, J. Biol.
Chem. 272 (1997) 29200–29206.
[12] D. Schechtman, M.L. Craske, V. Kheifets, T. Meyer, J. Schechtman, D. Mochly-Rosen,
A critical intramolecular interaction for protein kinase Cepsilon translocation,
J. Biol. Chem. 279 (2004) 15831–15840.
[13] R. Nesher, L. Waldman, E. Cerasi, Time-dependent inhibition of insulin release:
glucose–arginine interactions in the perfused rat pancreas, Diabetologia 26 (1984)
146–149.
[14] M. Gadot, G. Leibowitz, E. Shafrir, E. Cerasi, D.J. Gross, N. Kaiser, Hyperproinsu-
linemia and insulin deﬁciency in the diabetic Psammomys obesus, Endocrinology
135 (1994) 610–616.
[15] R. Nesher, N. Warwar, A. Khan, S. Efendic, E. Cerasi, N. Kaiser, Defective stimulus-
secretion coupling in islets of Psammomys obesus, an animal model for type 2
diabetes, Diabetes 50 (2001) 308–314.
[16] S.M. Elbashir, J. Harborth, K. Weber, T. Tuschl, Analysis of gene function in somatic
mammalian cells using small interfering RNAs, Methods 26 (2002) 199–213.
[17] H. Shinohara, N. Kayagaki, H. Yagita, N. Oyaizu, M. Ohba, T. Kuroki, Y. Ikawa, A
protective role of PKCe against TNF-related apoptosis-inducing ligand (TRAIL)-
induced apoptosis in glioma cells, Biochem. Biophys. Res. Commun. 284 (2001)
1162–1167.
[18] T. He, S. Zhou, L. da Costa, J. Yu, K. Kinzler, B. Vogelstein, A simpliﬁed system for
generating recombinant adenoviruses, Proc. Natl. Acad. Sci. U. S. A. 95 (1998)
2509–2514.
[19] P.A. Halban, C.J. Rhodes, S.E. Shoelson, High-performance liquid chromatography
(HPLC): a rapid, ﬂexible and sensitive method for separating islet proinsulin and
insulin, Diabetologia 29 (1986) 893–896.
[20] Y. Zambre, Z. Ling, X. Hou, A. Foriers, B. Van Den Bogaert, C. Van Schravendijk, D.
Pipeleers, Effect of glucose on production and release of proinsulin conversion
products by cultured human islets, J. Clin. Endocrinol. Metab. 83 (1998)
1234–1238.
[21] C.F. Mendez, I.B. Leibiger, B. Leibiger, M. Hoy, J. Gromada, P.O. Berggren, A.M.
Bertorello, Rapid association of protein kinase C-epsilon with insulin granules is
essential for insulin exocytosis, J. Biol. Chem. 278 (2003) 44753–44757.
[22] G. Gold, M.L. Gishizky, G.M. Grodsky, Evidence that glucose “marks” beta cells
resulting in preferential release of newly synthesized insulin, Science 218 (1982)
56–58 (New York, N.Y.
[23] P.A. Halban, Differential rates of release of newly synthesized and of stored insulin
from pancreatic islets, Endocrinology 110 (1982) 1183–1188.
[24] H. Sando, J. Borg, D.F. Steiner, Studies on the secretion of newly synthesized pro-
insulin and insulin from isolated rat islets of Langerhans, J. Clin. Invest. 51 (1972)
1476–1485.
[25] C.F. Van Schravendijk, R. Kiekens, D.G. Pipeleers, Pancreatic beta cell heterogeneity
in glucose-induced insulin secretion, J. Biol. Chem. 267 (1992) 21344–21348.
[26] M. Gadot, Y. Ariav, E. Cerasi, N. Kaiser, D.J. Gross, Hyperproinsulinemia in the
diabetic Psammomys obesus is a result of increased secretory demand on the beta-
cell, Endocrinology 136 (1995) 4218–4223.
[27] E. Gomez, M.L. Powell, I.C. Greenman, T.P. Herbert, Glucose-stimulated protein
synthesis in pancreatic beta-cells parallels an increase in the availability of the
translational ternary complex (eIF2-GTP.Met-tRNAi) and the dephosphorylation of
eIF2 alpha, J. Biol. Chem. 279 (2004) 53937–53946.
[28] D. Mochly-Rosen, Localization of protein kinases by anchoring proteins: a theme in
signal transduction, Science 268 (1995) 247–251.
[29] D. Mochly-Rosen, A.S. Gordon, Anchoring proteins for protein kinase C: a means
for isozyme selectivity, Faseb J. 12 (1998) 35–42.
[30] Y. Shirai, K. Kashiwagi, K. Yagi, N. Sakai, N. Saito, Distinct effects of fatty acids on
translocation of gamma- and epsilon-subspecies of protein kinase C, J. Cell Biol.
143 (1998) 511–521.
[31] C. Schmitz-Peiffer, D.R. Laybutt, J.G. Burchﬁeld, E. Gurisik, S. Narasimhan, C.J.
Mitchell, D.J. Pedersen, U. Braun, G.J. Cooney, M. Leitges, T.J. Biden, Inhibition of
PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin
clearance, Cell Metab 6 (2007) 320–328.
